Suppr超能文献

COVID-19 所致中度低氧血症患者的俯卧位治疗:多中心实用随机试验(COVID-PRONE)。

Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE).

机构信息

Division of General Internal Medicine, Sinai Health, Toronto, ON, Canada

General Internal Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

BMJ. 2022 Mar 23;376:e068585. doi: 10.1136/bmj-2021-068585.

Abstract

OBJECTIVES

To assess the effectiveness of prone positioning to reduce the risk of death or respiratory failure in non-critically ill patients admitted to hospital with covid-19.

DESIGN

Multicentre pragmatic randomised clinical trial.

SETTING

15 hospitals in Canada and the United States from May 2020 until May 2021.

PARTICIPANTS

Eligible patients had a laboratory confirmed or a clinically highly suspected diagnosis of covid-19, needed supplemental oxygen (up to 50% fraction of inspired oxygen), and were able to independently lie prone with verbal instruction. Of the 570 patients who were assessed for eligibility, 257 were randomised and 248 were included in the analysis.

INTERVENTION

Patients were randomised 1:1 to prone positioning (that is, instructing a patient to lie on their stomach while they are in bed) or standard of care (that is, no instruction to adopt prone position).

MAIN OUTCOME MEASURES

The primary outcome was a composite of in-hospital death, mechanical ventilation, or worsening respiratory failure defined as needing at least 60% fraction of inspired oxygen for at least 24 hours. Secondary outcomes included the change in the ratio of oxygen saturation to fraction of inspired oxygen.

RESULTS

The trial was stopped early on the basis of futility for the pre-specified primary outcome. The median time from hospital admission until randomisation was 1 day, the median age of patients was 56 (interquartile range 45-65) years, 89 (36%) patients were female, and 222 (90%) were receiving oxygen via nasal prongs at the time of randomisation. The median time spent prone in the first 72 hours was 6 (1.5-12.8) hours in total for the prone arm compared with 0 (0-2) hours in the control arm. The risk of the primary outcome was similar between the prone group (18 (14%) events) and the standard care group (17 (14%) events) (odds ratio 0.92, 95% confidence interval 0.44 to 1.92). The change in the ratio of oxygen saturation to fraction of inspired oxygen after 72 hours was similar for patients randomised to prone positioning and standard of care.

CONCLUSION

Among non-critically ill patients with hypoxaemia who were admitted to hospital with covid-19, a multifaceted intervention to increase prone positioning did not improve outcomes. However, wide confidence intervals preclude definitively ruling out benefit or harm. Adherence to prone positioning was poor, despite multiple efforts to increase it. Subsequent trials of prone positioning should aim to develop strategies to improve adherence to awake prone positioning.

STUDY REGISTRATION

ClinicalTrials.gov NCT04383613.

摘要

目的

评估俯卧位对降低因 COVID-19 住院的非危重症患者死亡或呼吸衰竭风险的效果。

设计

多中心实用随机临床试验。

地点

2020 年 5 月至 2021 年 5 月期间,加拿大和美国的 15 家医院。

参与者

符合条件的患者有实验室确诊或临床高度疑似 COVID-19 的诊断,需要补充氧气(最高达 50%吸入氧分数),并能在口头指导下独立俯卧。在评估了 570 名符合条件的患者后,257 名被随机分组,248 名纳入分析。

干预

患者被随机分配 1:1 接受俯卧位(即指导患者在卧床时俯卧)或标准治疗(即不指导采用俯卧位)。

主要结局指标

主要结局是院内死亡、机械通气或呼吸衰竭恶化的复合指标,定义为至少需要 60%吸入氧分数至少 24 小时。次要结局包括氧饱和度与吸入氧分数比值的变化。

结果

根据预先规定的主要结局,试验因无效而提前终止。从住院到随机分组的中位时间为 1 天,患者的中位年龄为 56(四分位距 45-65)岁,89(36%)名患者为女性,222(90%)名患者在随机分组时通过鼻插管吸氧。在最初的 72 小时内,俯卧组总共俯卧 6(1.5-12.8)小时,而对照组为 0(0-2)小时。俯卧组和标准治疗组的主要结局风险相似(18 名(14%)事件与 17 名(14%)事件)(比值比 0.92,95%置信区间 0.44 至 1.92)。俯卧组和标准治疗组患者在 72 小时后氧饱和度与吸入氧分数比值的变化相似。

结论

在因 COVID-19 住院的低氧血症非危重症患者中,增加俯卧位的多方面干预措施并未改善结局。然而,广泛的置信区间不能排除获益或危害。尽管采取了多种措施来增加俯卧位,但其依从性仍很差。随后的俯卧位试验应旨在制定策略,以提高清醒俯卧位的依从性。

试验注册

ClinicalTrials.gov NCT04383613。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6a/8941343/ff82c10c9a0e/fram068585.f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验